Looking for MCCs with consistently low nitrite?

Looking for MCCs with consistently low nitrite?

DFE Pharma’s Pharmacel® MCC portfolio now features nitrite values on the Certificate of Analysis with specifications ≤ 0.1ppm for each of their three grades: Pharmacel® 101, Pharmacel® 102, and Pharmacel® 112.

Discover the difference with Pharmacel®.

Our robust quality management system delivers batch-to-batch and year-on-year consistency. Download the brochure.

Test DFE Pharma’s IPEC GMP Quality standards-compliant Pharmacel® grades. Request a sample pack. Or, explore our full microcrystalline cellulose (MCC) portfolio. 

Let our team of technical and regulatory experts help you optimize your formulations. Schedule a free technical presentation. 

Our commitment to reliability means you can focus on what matters most – bringing your medicines to patients globally, moving to a healthier world.

Back to blog

Low Nitrite MCCs

Whitepapers

  • Modeling Excipient Selection's Impact on Nitros...

    Risk control for nitrosamine impurities in drug products is a major challenge in the industry. Nitrosamines can form during drug product manufacturing and storage through the reaction of nitrites with...

    Modeling Excipient Selection's Impact on Nitros...

    Risk control for nitrosamine impurities in drug products is a major challenge in the industry. Nitrosamines can form during drug product manufacturing and storage through the reaction of nitrites with...

  • New Standards in Visible Particle Detection in ...

    Visible particles in pharmaceutical powder excipients are typically counted manually. However, because the human eye’s ability to detect particles is subjective, manual counting is prone to operator-dependent bias and potential...

    New Standards in Visible Particle Detection in ...

    Visible particles in pharmaceutical powder excipients are typically counted manually. However, because the human eye’s ability to detect particles is subjective, manual counting is prone to operator-dependent bias and potential...

  • Nitrosamines Risk Mitigation: The critical role...

    Evaluating nitrosamines in drug products has become a big challenge for formulators in the pharmaceutical industry. When excipients are considered as a potential risk factor during the drug product risk assessment,...

    Nitrosamines Risk Mitigation: The critical role...

    Evaluating nitrosamines in drug products has become a big challenge for formulators in the pharmaceutical industry. When excipients are considered as a potential risk factor during the drug product risk assessment,...

1 4